A multi-centre, open-label randomized trial to assess the efficacy, safety and tolerability of Triple Artemisinin-based Combination Therapies (TACTs) compared to Artemisinin-based Combination Therapies (ACTs) in uncomplicated falciparum malaria and to map the geographical spread of artemisinin and partner drug resistance. Samples submitted in this study are dried blood spots.
1180 Tracking Artemisinin Resistance Collaboration (TRAC II) with SpotMalaria
Key People
Rob van der Pluijm
Mahidol Oxford Tropical Medicine Research Unit (MORU), Thailand
Prof Olivo Miotto
Senior Informatics Fellow
Mahidol Oxford Tropical Medicine Research Unit (MORU), Thailand
Prof Arjen Dondorp
Mahidol-Oxford Tropical Medicine Research Unit (MORU), Thailand
Centre for Tropical Medicine and Global Health, University of Oxford, UK